Table 5 Time from administration of reversal agents to recovery of TOFR to 0.7, 0.8, 0.9, and 1.0 in patients with a deep/moderate or shallow/minimal block
Neostigmine group (n = 34) | Sugammadex group (n = 36) | p-value | |
|---|---|---|---|
Deep/moderate block subgroup | |||
Recovery of TOFR to 0.9 | |||
Number of patients | 15 (100%) | 21 (100%) | |
Median (IQR), s | 420 (246–896) | 115 (78–180) | < 0.001 |
Recovery of TOFR to 1.0 | |||
Number of patients | 9 (88.2%) | 16 (80.6%) | |
Median (IQR), s | 472 (306–688) | 151 (101–208) | < 0.001 |
Time to extubation | |||
Median (IQR), min | 23 (17–43) | 12 (7–15) | 0.004 |
Time to discharge to the ward | |||
Median (IQR), min | 93 (85–109) | 102 (76–123) | 0.362 |
Recovery of TOFR to 0.9 within 5 min from reversal administration | 5 (33.3%) | 19 (90.5%) | 0.001 |
Recovery of TOFR to 0.9 within 10 min from reversal administration | 10 (66.7%) | 21 (100%) | 0.008 |
Recovery of TOFR to 1.0 within 10 min from reversal administration | 7 (53.8%) | 21 (100%) | 0.001 |
Shallow/minimal block subgroup | |||
Recovery of TOFR to 0.9 | |||
Number of patients | 19 (88.2%) | 15 (75.0%) | |
Median (IQR), s | 184 (121–300) | 44 (35–80) | < 0.001 |
Recovery of TOFR to 1.0 | |||
Number of patients | 9 (100%) | 15 (100%) | |
Median (IQR), sec | 229 (119–452) | 86 (41–140) | 0.003 |
Recovery of TOFR to 0.9 within 5 min from reversal administration | 15 (78.9%) | 15 (100%) | 0.084 |
Recovery of TOFR to 0.9 within 10 min from reversal administration | 16 (84.2%) | 15 (100%) | 0.162 |
Recovery of TOFR to 1.0 within 10 min from reversal administration | 13 (72.2%) | 15 (100%) | 0.036 |
Time to extubation | |||
Median (IQR), min | 13.2 (8.6–20.6) | 11.1 (8.2–15) | 0.011 |
Time to discharge to the ward | |||
Median (IQR), min | 89 (62–119) | 84 (75–101) | 0.572 |